Locations
Vancouver, BC, Canada · North Vancouver, BC, Canada
industry
Biotechnology · DeepTech · Health
Size
11-50 employees
Stage
Series B
founded in
2017
SaNOtize is a global pharmaceutical company that has developed a first-in-class technology to harness the antimicrobial properties of nitric oxide (NO). This innovative approach aims to treat and prevent upper respiratory and dermal infections, including drug-resistant microbes. Their key product, a nitric oxide releasing nasal spray, is designed to combat various infections such as strep throat, sinusitis, and cold and flu. With a focus on clinical development and a commitment to addressing significant health challenges, SaNOtize positions itself as a leader in the pharmaceutical industry, leveraging its unique technology to create impactful health solutions.
Something looks off?